Lawton Alison Frances Insider Trades

Insider Trading History

Track insider trading activity for Lawton Alison Frances. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $533k 6,090 shares
Last Trade
May 21, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$546k 6,090 shares
$89.63
$87.53
ProQR Therapeutics N.V
ProQR Therapeutics N.V PRQR
Director
Holding Value $0 0 shares
Last Trade
Mar 18, 2026 Sale
$422k 245,599 shares
$1.72
$1.89
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $1.09M 12,500 shares
Last Trade
May 22, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$230k 12,500 shares
$18.36
$87.53
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $387k 96,667 shares
Last Trade
Jun 10, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.4M 45,000 shares
$31.20
$4.00
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $963k 11,000 shares
Last Trade
May 23, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$239k 11,000 shares
$21.77
$87.53
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $4.55k 6,500 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.55k 6,500 shares
$0.70
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $569k 6,500 shares
Last Trade
Sep 11, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.55k 6,500 shares
$0.70
$87.53
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $23.4M 1,950,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.2M 1,950,000 shares
$11.40
$12.01
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $189M 1,950,000 shares
Last Trade
Jun 22, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$97.05
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $207k 51,667 shares
Last Trade
Jun 13, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.36M 45,000 shares
$74.70
$4.00
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $14k 20,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 20,000 shares
$1.21
$0.70
Dianthus Therapeutics
Dianthus Therapeutics DNTH
Director
Holding Value $1.75M 20,000 shares
Last Trade
Jun 28, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$24.2k 20,000 shares
$1.21
$87.53
Spyre Therapeutics
Spyre Therapeutics SYRE
Director
Holding Value $4.17M 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
No data
No data
$97.05
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $516k 43,000 shares
Last Trade
Jun 07, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.57M 86,000 shares
$18.25
$12.01
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $26.7k 6,667 shares
Last Trade
Jun 06, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$232k 6,667 shares
$34.80
$4.00
Aeglea BioTherapeutics
Aeglea BioTherapeutics AGLE
Director
Holding Value $480k 40,000 shares
Last Trade
Jun 08, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$6.8M 40,000 shares
$170.00
$12.01
X4 Pharmaceuticals
X4 Pharmaceuticals XFOR
Director
Holding Value $24k 6,000 shares
Last Trade
Jun 02, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.71M 6,000 shares
$285.00
$4.00
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $12.7k 18,188 shares
Last Trade
Jun 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$235k 18,188 shares
$12.91
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $0 0 shares
Last Trade
Dec 22, 2020 Sale
$410k 52,244 shares
$7.85
$0.70
Magenta Therapeutics
Magenta Therapeutics MGTA
Director
Holding Value $25.4k 36,377 shares
Last Trade
Dec 22, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$286k 36,377 shares
$7.85
$0.70

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up